Bipolar Disorder, Schizophrenia, and Metabolic Syndrome
To the Editor: In the March issue, Vancampfort et al. (1) reported valuable data by conducting a meta-analysis of published studies on rates of metabolic syndrome among people with bipolar disorder. In the general findings paragraph, they also compared prevalence of metabolic syndrome among different psychiatric disorders. Rates appeared to be significantly higher in bipolar patients, 37.3% (95% confidence interval [CI]=36.1–39.0), than in schizophrenia patients, 32.5% (95% CI=30.1–35.0) (2). The authors advised caution in interpreting this finding because of the lack of data allowing direct comparison between individuals with schizophrenia and bipolar disorder. However, we believe that this is an important issue that should be more thoroughly assessed and commented on. Among articles screened for suitability for inclusion in meta-analysis, 11 provided data on metabolic syndrome prevalence rates of 3,888 unique participants: 1,572 with bipolar disorder and 2,316 with schizophrenia. Therefore, there may well be sufficient data for a supplementary analysis assessing differences on metabolic syndrome rates between these diagnostic subgroups.
A pooled analysis based on a random-effects model and using odds ratio as an association measure is depicted in Figure 1. The number of individuals with metabolic syndrome was 705 among bipolar patients and 890 among schizophrenia patients. The pooled odds ratio (bipolar compared with schizophrenia) was 1.01 (95% CI=0.82–1.24; p=0.93), with low heterogeneity across the studies (I2=31%; p=0.15). In addition, a subanalysis based on four studies reporting significantly higher rates of antipsychotic prescriptions in people with schizophrenia revealed a similar chance of metabolic syndrome for individuals with bipolar disorder (odds ratio=0.98, 95% CI=0.70–1.38; p=0.91). Further subanalyses did not reveal any statistical difference. We believe these findings may well complement those reported by Vancampfort et al. (1). Individuals with bipolar disorder and schizophrenia have comparable chances of having metabolic syndrome. Despite important differences in clinical features, these individuals may actually share a number of health behaviors, including poor physical activity, unhealthy diet, excessive alcohol intake, and smoking habits. Future research should assess the relative contribution to metabolic syndrome not only of different psychiatric diagnoses, but also of components such as genetics, antipsychotic medication use, lifestyle, and health behaviors.
1 : Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. Am J Psychiatry 2013; 170:265–274Link, Google Scholar
2 : Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: a systematic review and meta-analysis. Schizophr Bull 2013; 39:306–318Crossref, Medline, Google Scholar
3 : The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela. Schizophr Res 2011; 126:93–102Crossref, Medline, Google Scholar
4 : The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry 2007; 68:917–923Crossref, Medline, Google Scholar
5 : Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008; 10:788–797Crossref, Medline, Google Scholar
6 : The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J Psychopharmacol 2010; 24:867–873Crossref, Medline, Google Scholar
7 : Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 2009; 190:176–179Crossref, Medline, Google Scholar
8 : Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One 2011; 6:e19298Crossref, Medline, Google Scholar
9 : Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India. Indian J Med Res 2010; 131:46–52Medline, Google Scholar
10 : Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database. Eur Psychiatry 2008; 23:100–108Crossref, Medline, Google Scholar
11 : The prevalence of metabolic syndrome among psychiatric inpatients in Brazil: Rev Bras Psiquiatr. 2007; 29:330–336Crossref, Medline, Google Scholar
12 : Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008; 69:1319–1327Crossref, Medline, Google Scholar
13 : Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res 2011; 189:21–25Crossref, Medline, Google Scholar
